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Abstract 
Background 
Small for gestational age (SGA) infants are at increased risk of morbidity and mortality. We 
sought to identify risk factors associated with SGA and examined the potential for reducing 
the proportion of infants with SGA at a population level. 
Methods 
Birth and hospital records were linked for births occurring in 2007–2010 in New South 
Wales, Australia. The analysis was stratified into three groups: preterm births, term births to 
non-diabetic mothers and term births to diabetic mothers. Logistic regression was used to 
examine the association between SGA and a range of socio-demographic and behavioural 
factors and health conditions, with generalised estimating equations to account for 
correlation among births to the same mother. Model-based population attributable fractions 
(PAFs) were calculated for risk factors that were considered causative and potentially 
modifiable. 
Results 
Of 28,126 SGA infants, the largest group was term infants of non-diabetic mothers (88.5%), 
followed by term infants of diabetic mothers (6.3%) and preterm infants (5.3%). The highest 
PAFs were for smoking: 12.4% for preterm SGA and 10.3% for term SGA infants of non-
diabetic mothers. Other risk factors for SGA that were considered modifiable included: illicit 
drug dependency or abuse in pregnancy in all three groups, and pregnancy hypertension 
and late commencement of antenatal care in term infants of non-diabetic mothers, but PAFs 
were less than 3%. 
Conclusions 
There are opportunities for modest reduction of the prevalence of SGA through reduction in 
smoking in pregnancy, and possibly earlier commencement of antenatal care and improved 
management of high-risk pregnancies. 
Keywords: small for gestational age, population attributable fraction, record linkage 
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Background 
Every year more than 20 million infants are born with low birth weight (LBW) (less than 2500 
grams), accounting for 15% of births globally. Infants with LBW are at increased risk of 
morbidity and mortality, inhibited growth and cognitive development, and poor quality of life 
in infancy, childhood and adult life [1]. LBW can result from prematurity, intrauterine growth 
retardation, or a combination of these. Small for gestational age (SGA) is preferable to LBW 
as a measurement of adequate fetal growth as SGA takes into account the variation in 
birthweights across gestational ages and infant sex. While the definition of SGA varies 
according to the context [2], SGA is typically defined as birthweight less than the 10th 
percentile of the population gestational age- and sex-specific birthweight percentiles [3].  
 
The pathophysiological mechanisms of SGA are multifactorial, and are attributable to a 
complex interplay between socio-demographic, biological, medical and behavioural factors 
[2]. Socio-demographic factors include: Aboriginality (Aboriginal mothers) [4], minority race 
[5], marital status (single and unmarried mothers) [6], maternal age (younger and older 
mothers) [3, 7] and socio-economic status (socioeconomically disadvantaged) [8]. Obstetric 
history factors include: nulliparity [9], previous infant with SGA [3, 10], previous preterm birth 
[11], previous stillbirth [3], previous abortion [12], maternal history of being SGA [11], and 
short and long inter-pregnancy interval [13]. Chronic and pregnancy-specific medical 
conditions include: diabetes [3], hypertension [14], placenta abruption [3], placenta praevia 
[3], chronic diseases (cardiac disease [15], chronic kidney disease [3], asthma/chronic 
obstructive pulmonary disease [16], thyroid disorder and autoimmune disease [3]) and 
infections such as urinary tract infection [10]. Maternal health behaviours during pregnancy 
include: smoking [3], illicit drug use [17], alcohol use [18] and lack of nutritional intake [11]. 
Other factors include: low maternal weight gain [11], body mass index [3], inadequate 
antenatal care [11], assisted reproductive technology use [19], exposure to toxic substances 
[11], maternal work and psychosocial stress [11], parental factors [11], vigorous physical 
activity [10] and fetus with congenital anomaly [11]. 
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There is little information on the risks for SGA at a population level [20-22]. A recently 
published population-based study from the British Columbia Perinatal Database Registry 
investigated a limited set of maternal risk factors for SGA (i.e., maternal age, maternal height 
and weight, smoking in pregnancy, hypertension and placental disorders) as potential 
targets of intervention to reduce socio-economic SGA inequality by calculating the 
population attributable fractions for each factor [22]. Other published estimates of population 
attributable fraction are largely limited to only smoking in pregnancy [23-25]. 
 
New South Wales (NSW) is the most populous state in Australia with approximately 7 million 
people, representing 32% of the Australian population [26]. In 2009 there were 96,434 births 
in NSW, accounting for 32% of births in Australia [27]. The NSW Government’s State Health 
Plan–A New Direction for NSW towards 2010 on Strengthening Primary Health and 
Continuing Care in the Community aims to counteract the impact of genetic, social and 
environmental factors which predispose infants to ill health, through promotion and 
implementation of early interventions that lead to the birth of healthy infants and assist them 
in reaching their full potential for healthy and productive lives [28]. To inform the NSW 
Government on priority areas for prevention activities, it is important to identify and quantify 
risk factors influencing SGA infants at a population level; of particular interest are potentially 
modifiable risk factors. The aims of this study were to identify population risk factors 
associated with SGA among preterm and term infants and examine the potential for reducing 
the proportion of infants with SGA at a population level. 
Methods 
Study population 
The study population comprised 299,190 singleton live births with gestational age between 
24 and 44 weeks in NSW from 2007 to 2010 for 249,429 mothers with a complete obstetric 
history. Mothers with a complete obstetric history were defined as those who gave birth in 
2007 to 2010 with the reported number of previous pregnancies at each birth consistent with 
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the number of linked historical birth records in the period 1994 to 2010.  Restriction by 
gestational age was a consequence of unreliable percentile estimates for infants less than 
24 or greater than 44 weeks gestation due to insufficient data. Multifetal pregnancies and 
stillbirths were excluded, as they carry a different set of risks compared to singleton live 
births.  
Data sources 
Data were obtained from two linked NSW population databases: the Perinatal Data 
Collection (PDC) and Admitted Patient Data (APD). The PDC is a legislated population-
based surveillance system covering all live births, and stillbirths of at least 20 weeks 
gestation or at least 400 grams birthweight. Information is recorded by either the midwife or 
medical practitioner providing maternity care and includes demographic, medical and 
obstetric information on the mother, as well as infant outcomes. The APD is a census of all 
admitted patient services that includes summary discharge information for every inpatient 
that is admitted to any NSW public or private hospital. Diagnosis and procedures for each 
admission are coded according to the 10th revision of the International Classification of 
Disease, Australian Modification and the Australian Classification of Health Intervention 
respectively [29]. 
 
Record linkage was carried out by the NSW Centre for Health Record Linkage (CHeReL) 
[30] using a best practice approach in preserving privacy [31] and the open source 
probabilistic record linkage software ChoiceMaker [32]. This involves a process of blocking 
and matching combinations of the following variables with identifying information: full name, 
address, sex, date of birth, country of birth, hospital code, medical record number, hospital 
dates of admission and discharge, hospital transferred to, hospital transferred from, and date 
of death. Each match was assigned a probability match weight and borderline matches were 
subject to clerical review [33]. Longitudinally linked birth records from 1994 to 2010 were 
used to obtain an obstetric history for mothers who gave birth during 2007 to 2010. Birth and 
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hospital records were linked cross-sectionally for the maternal admission where the woman 
gave birth and longitudinally for hospitalisations prior to birth. Over 99% of birth records 
linked to a hospital record. The CHeReL reported the quality of the record linkage for this 
study as less than one in 1000 false positive links and less than two in 1000 missed links. 
The researchers were provided with anonymised data. Ethical approval for the study was 
obtained from the NSW Population and Health Services Research Ethics Committee. 
Risk factors 
The following information was obtained from birth records: socio-demographic factors 
including mother’s Aboriginality, country of birth, maternal age, antenatal care visit less than 
14 weeks gestation, and socio-economic status (the Australian Bureau of Statistics Index of 
Economic Resources) [34] and geographic remoteness (Accessibility/Remoteness Index of 
Australia) [35] based on Statistical Local Area of residence; and information derived from the 
complete obstetric history including parity, inter-pregnancy interval, previous birth by 
caesarean section, previous preterm birth, previous stillbirth and previous SGA infant. The 
following information was obtained from birth records linked to hospital records: maternal 
medical conditions including diabetes (pre-existing or gestational), hypertensive disorders 
(chronic or gestational hypertension, preeclampsia or eclampsia), placenta abruption, 
placenta praevia, urinary tract infection, chronic diseases (fives years lookback) [36] (cardiac 
diseases, chronic kidney disease, asthma/chronic obstructive pulmonary disease (COPD), 
thyroid disorders and autoimmune diseases), and maternal health behaviours during 
pregnancy including smoking, alcohol and illicit drug dependency or abuse. Information 
about congenital anomalies was obtained from infant birth admission records. Only variables 
that are accurately reported and validated were included in the analysis [37-40].  
Outcome variable 
SGA was defined as less than the 10th percentile of Australian national gestational age- and 
sex-specific birthweight percentiles [41]. The 10th percentile for infants of 39 weeks gestation 
is approximately 2500 grams birthweight regardless of infant sex. Births were stratified into 
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preterm and term groups, and SGA and non-SGA infants were compared within each group. 
Birthweight is recorded to the nearest five grams. Gestational age is recorded in completed 
weeks of gestation determined by the best clinical estimate based on early pregnancy 
ultrasound or the first day of the last menstrual period. 
Analysis 
Using infants who were not SGA as the comparison group, the association between each 
study variable and SGA was examined for preterm and term groups. Descriptive analysis 
was carried out to examine univariate associations. Variance inflation factors were used to 
assess multicollinearity between variables. Variables with P < 0.10 based on crude chi-
squared tests were included in the initial multivariable model. Using logistic regression and 
backward elimination, the overall least significant variable was progressively removed from 
each model until only variables significant at P < 0.01 remained or if they were confounders 
(change in adjusted odds ratio [aOR] of 10% or more). Once a main effects model was 
determined, all eliminated variables were added back into the model independently and their 
statistical significance checked. All two-way biologically plausible interactions were also 
considered and retained if P < 0.01. For term analysis, infants were divided into two groups 
for diabetic and non-diabetic mothers, as the risks of SGA for a number of study variables 
were found to be modified by whether the mother had diabetes. 
 
Once the final model was determined, generalised estimating equations (GEEs) with a logit 
link, an exchangeable working correlation matrix and robust standard errors were used to 
obtain the aORs, while accounting for correlation among births to the same mother in the 
study period [42]. Model-based population attributable fractions (PAFs) for risk factors that 
were considered causative and potentially modifiable were obtained by calculating the 
difference in the expected number of SGA infants between the final adjusted model and the 
same model with the risk factor’s regression coefficient(s) set to zero (representing removal 
from the population and/or effective management), as a percentage of the former [43]. 
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Ninety-five per cent bias-corrected confidence intervals were computed via bootstrap with 
10,000 replicates. The PAFs represent the greatest attainable reduction in the rate of SGA 
that would be observed if the population was free of the risk factor of interest. Analysis was 
carried out using SAS 9.3 (SAS Institute, USA) [44] and Stata SE 11.1 (Statacorp, USA) 
[45]. 
Results 
There were 308,989 mothers with at least one singleton live birth with a gestational age 
between 24 and 44 weeks in NSW in the period 2007 to 2010. Of these, 259,380 (83.9%) 
had a complete obstetric history: 28,197 (85.5%) mothers of SGA infants and 237,207 
(83.8%) mothers of non-SGA infants. Incomplete obstetric history was more likely to occur in 
mothers with high-risk pregnancy, i.e., older maternal age (≥35 years: 37.9% vs. 20.8%), 
multiparous, socio-economically disadvantaged (4th–5th quintiles: 45.0% vs. 37.9%), 
residence in a geographically remote area (10.5% vs. 8.6%), smoking in pregnancy (18.1% 
vs. 11.1%) and late commencement of antenatal care (24.9% vs. 18.6%). Of the 312,047 
birth records for these 308,989 mothers, 99.1% were linked to hospital records, and 96.8% 
of these linked birth and hospital records had complete information for all variables of 
interest. The final analysis dataset comprised 299,190 singleton live births relating to 
249,429 mothers; 201,456 (80.8%) mothers had one birth, 46,215 (18.5%) mothers had two 
births and 1758 (0.7%) mothers had three or more births. 
 
Of all singleton live births, 15,541 (5.2%) were preterm and 283,649 (94.8%) were term. 
There were 28,126 SGA infants, of whom 24,883 (88.5%) were term infants of non-diabetic 
mothers, 1765 (6.3%) were term infants of diabetic mothers and 1478 (5.3%) were preterm 
infants. Results are presented separately for the three groups—preterm SGA infant (Table 
1), term SGA infant of diabetic mother (Table 2) and term SGA infant of non-diabetic mother 
(Table 3).  
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In the crude analysis, the following risk factors were found to be associated with SGA infant: 
 All three groups: overseas-born mother, increasing socio-economic disadvantage, inter-
pregnancy interval (<6 or ≥42 months), nulliparity, increasing number of previous SGA 
infants, illicit drug dependency or abuse in pregnancy, and smoking in pregnancy; and a 
protective effect of previous caesarean section.  
 Preterm SGA infant: additionally, Aboriginal mother, chronic or pregnancy hypertension, 
autoimmune diseases and fetus with a congenital anomaly; and protective effects of 
residence in a geographically remote area, two previous caesarean sections, diabetes 
and placenta praevia.  
 Term SGA infant of a diabetic mother: additionally, residence in a major city and late 
commencement of antenatal care; and protective effects of previous preterm birth and 
chronic kidney disease. 
 Term SGA infant of a non-diabetic mother: additionally, Aboriginal mother, increasing 
geographic remoteness of residence, younger maternal age, increasing number of 
previous preterm births, chronic or pregnancy hypertension, placental abruption, urinary 
tract infection, asthma/COPD,  alcohol use in pregnancy and late commencement of 
antenatal care; and there was a U-shaped association with number of previous 
pregnancies. 
 
After multivariable adjustment, the highest risk of a SGA infant for all three groups was 
associated with increasing number of previous SGA infants, with a dose-response 
relationship that was strongest for term SGA infants of non-diabetic mothers; while illicit drug 
dependency or abuse in pregnancy, smoking in pregnancy, nulliparity and overseas-born 
mother remained moderately strong risk factors with aORs of 1.5 to 3.2 across the groups. 
Socio-economic disadvantage was also retained in all three groups; while the effect was 
relatively small with aORs of less than 1.5, a clear pattern of increasing risk of SGA with 
increasing socio-economic disadvantage was observed for term SGA infants of non-diabetic 
mothers.  In addition, for preterm SGA infants, pregnancy hypertension and fetus with a 
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congenital anomaly remained as strong risk factors, while maternal diabetes provided a 
significant protective effect. For non-diabetic mothers, Aboriginal mothers retained a higher 
risk for a term SGA infant, as did mothers with previous preterm births, chronic or pregnancy 
hypertension, placental abruption and fetus with a congenital anomaly; previous caesarean 
section retained a slight protective effect.  
 
There was substantial variation in PAFs for SGA across the three infant groups. Among 
preterm infants, the greatest risk for SGA was associated with pregnancy hypertension (PAF 
28.8%), followed by smoking in pregnancy (PAF 12.4%) and previous SGA (PAFs 3.1–
9.8%), with chronic hypertension and illicit drug dependency or abuse in pregnancy having 
modest PAFs of 1.5–3%. Among term infants of diabetic mothers, a similar pattern was 
observed, but to a much lesser extent (e.g., previous SGA: PAF 1.4–7.3% and smoking in 
pregnancy: PAF 2.5%). Among term infants of non-diabetic mothers, SGA was highly 
attributable to previous SGA infant (PAFs 0.5–11.2%) and smoking in pregnancy (PAF 
10.3%). Previous preterm birth or stillbirth, chronic hypertension, placenta abruption, 
placenta praevia, illicit drug dependency or abuse in pregnancy and late commencement of 
antenatal care each contributed a PAF of less than 1.5%. 
Discussion 
We examined risk factors for SGA and estimated PAFs for potentially modifiable factors 
among three groups of liveborn infants of at least 24 weeks gestation in NSW. Of the 28,126 
SGA infants in the study, the largest group (88.5%) was term infants of non-diabetic 
mothers, while 6.3% were term infants of diabetic mothers and 5.3% were preterm infants. 
 
After multivariable adjustment, we found several risk factors that were consistently 
associated with SGA for all three groups of infants examined. These factors include: 
overseas-born mothers, nulliparity, increasing socio-economic disadvantage, increasing 
number of previous SGA infants, and smoking and illicit drug dependency or abuse in 
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pregnancy. Of these, smoking and illicit drug dependency or abuse in pregnancy are 
potentially modifiable. The PAFs for smoking in pregnancy were 12.4% for preterm SGA and 
10.3% for term SGA infant of a non-diabetic mother, reflecting the relatively high prevalence 
of smoking as a risk factor among pregnant mothers, and 2.5% for term SGA infant of a 
diabetic mother, reflecting the propensity for diabetic mothers to have large infants. The 
PAFs for illicit drug dependency or abuse in pregnancy were low and ranged from 0.3% to 
1.5% among the three infant groups. The effect of illicit drug dependency or abuse in 
pregnancy on SGA is likely to be under-estimated as it is only recorded on the hospital data 
where there is a history of dependency or abuse and this affects care during the hospital 
admission.  
 
For term infants of non-diabetic mothers, the largest population of SGA infants, the 
remaining risk factors for SGA that were considered modifiable included chronic or 
pregnancy hypertension and late commencement of antenatal care at 14 weeks gestation or 
more, though the PAFs for these were low at 1.2% and 0.2% for pregnancy and chronic 
hypertension respectively, and 0.8% for late commencement of antenatal care.  
 
A history of previous preterm birth, stillbirth or SGA infant was associated with term SGA 
infant of both diabetic and non-diabetic mothers in the current pregnancy. A history of 
previous SGA infant was associated with preterm SGA infant in the current pregnancy. While 
past medical or obstetric history is not modifiable for the current pregnancy, the PAFs for 
term infants of non-diabetic mothers with a history of one previous SGA infant was 11.2% 
and for preterm infants was 9.8%, highlighting the importance of careful monitoring of these 
mothers in the current pregnancy.  
 
We found that previous caesarean section was slightly protective against having a SGA 
infant in the current pregnancy. This may be related to closer monitoring of these mothers 
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leading to delivery of infants who are failing to grow or otherwise at risk before the fetus 
becomes seriously growth restricted.  
 
The strength of this study is the use of longitudinally linked population-based data allowing 
validation of parity of individual mothers. This ensured completeness of the obstetric 
histories and improved the accuracy of the selected sample [46]. Although mothers with 
high-risk pregnancy were more likely to have an incomplete obstetric history, the patterns of 
characteristics for mothers with complete or incomplete obstetric history were similar for 
SGA and non-SGA groups (data not shown). An important contribution of this study is the 
calculation of the PAFs, which represent the potential reduction in SGA births that is 
achievable if the effects of the risk factors were eliminated in the population.  
 
We were unable to adjust for some risk factors for SGA infant because the relevant 
information is not routinely collected, such as previous abortions, assisted reproductive 
technology use and maternal nutrition. The persistent association between SGA and socio-
economic disadvantage, and between SGA infants born to Aboriginal mothers, after 
multivariable adjustment, suggests the existence of some unmeasured risk factors for which 
socio-economic status and Aboriginality are proxies. We were also unable to identify which 
infants came from small families and were genetically destined to be small rather than being 
SGA. 
 
When considering the health of populations, the PAF is important because it takes into 
account both the level of individual risk and the prevalence of the risk factor in the 
population. We suggest that the greatest potential for prevention of SGA in the NSW 
maternity population lies in reducing smoking in pregnancy. A range of interventions have 
been shown to be effective in reducing smoking rates in mothers [47]. Smaller gains in 
preventing SGA could be achieved through reduction in illicit drug dependency and abuse in 
pregnancy, improved management of hypertension and targeted education to mothers about 
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improving antenatal care in the first trimester, adopting healthy lifestyles and optimising care 
for medical conditions. There may be potential for reducing the rates of SGA infants among 
mothers with a history of previous preterm birth, stillbirth or SGA infant through closer 
monitoring of these high-risk pregnancies. Further research into the underlying biological 
mechanisms for SGA may reveal further potential for prevention.  
Conclusions 
SGA is associated with a range of demographic, pregnancy history and behavioural factors, 
and maternal medical conditions. There are opportunities for modest reduction of the 
prevalence of SGA through reduction in smoking in pregnancy, and possibly earlier 
commencement of antenatal care and improved management of high-risk pregnancies. 
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Tables 
Table 1 – Crude and adjusted odds ratios and population attributable fractions for preterm SGA infants, New South Wales, 2007–2010 
Study variable  Preterm (<37 weeks gestation) 
SGA  
(N = 1478) 
Non-SGA     
(N = 14,063) 
Crude OR 
 (95% CI) 
Adjusted OR 
 (95% CI) 
Model-based PAF 
 (95% CI) 
n (%) n (%) 
Country of birth and Aboriginality of the mother 
     Aboriginal Australian 94 (6.4) 711 (5.1) 1.42 [1.13,1.78] 1.08 [0.84,1.39] 
 Non-Aboriginal Australian† 898 (60.8) 9,614 (68.4) 1.00 1.00 
 Non-Australian 486 (32.9) 3,738 (26.6) 1.40 [1.24,1.57] 1.67 [1.46,1.90] 
 ARIA+ remoteness  
     Major cities 968 (65.5) 9,242 (65.7) 0.95 [0.84,1.07] 0.88 [0.77,1.01] 
 Inner regional† 401 (27.1) 3,612 (25.7) 1.00 1.00 
 Outer regional 102 (6.9) 1,064 (7.6) 0.87 [0.69,1.09] 0.77 [0.60,0.98] 
 Remote 7 (0.5) 145 (1.0) 0.42 [0.20,0.90] 0.36 [0.17,0.78] 
 Maternal age 
     <20 years 79 (5.4) 731 (5.2) 0.95 [0.74,1.23] 
Not retained 
 20–24 years 273 (18.5) 2,172 (15.4) 1.13 [0.96,1.33] 
 25–29 years† 420 (28.4) 3,770 (26.8) 1.00 
 30–34 years 399 (27.0) 4,341 (30.9) 0.82 [0.71,0.95] 
 35–39 years 237 (16.0) 2,505 (17.8) 0.85 [0.72,1.00] 
 ≥40 years 70 (4.7) 544 (3.9) 1.15 [0.88,1.51] 
 Socio-economic group 
    
 
1st quintile (Most advantaged)† 260 (17.6) 2,845 (20.2) 1.00 
(1st–4th quintiles 
vs. 5th quintile) 
2nd quintile 274 (18.5) 2,838 (20.2) 1.06 [0.88,1.26] 
3rd quintile 296 (20.0) 2,815 (20.0) 1.15 [0.96,1.37] 
4th quintile 268 (18.1) 2,475 (17.6) 1.18 [0.98,1.41] 
5th quintile (Most disadvantaged) 380 (25.7) 3,090 (22.0) 1.34 [1.14,1.59] 1.22 [1.07,1.40] 
 Inter-pregnancy interval 
     6–41 months, nulliparity† 1,275 (86.3) 11,917 (84.7) 1.00 Not retained  <6 or ≥42 months 203 (13.7) 2,146 (15.3) 1.28 [1.07,1.54] 
 Number of previous pregnancies 
     0 943 (63.8) 7,405 (52.7) 1.50 [1.32,1.70] 1.89 [1.62,2.19] 
 1† 339 (22.9) 3,996 (28.4) 1.00 1.00 
 2 108 (7.3) 1,697 (12.1) 0.75 [0.60,0.93] 0.57 [0.45,0.70] 
 3 59 (4.0) 644 (4.6) 1.08 [0.81,1.44] (0, 2+ vs. 1) 
 
4+ 29 (2.0) 321 (2.3) 1.06 [0.71,1.60] 
Number of previous births by caesarean  
     0† 1,289 (87.2) 11,825 (84.1) 1.00 
Not retained  1 157 (10.6) 1,671 (11.9) 0.85 [0.71,1.01] 
 2+ 32 (2.2) 567 (4.0) 0.51 [0.35,0.73] 
 Number of previous preterm births 
     0† 1,312 (88.8) 12,206 (86.8) 1.00 
Not retained  1 150 (10.2) 1,601 (11.4) 0.87 [0.73,1.03] 
 2+ 16 (1.1) 256 (1.8) 0.60 [0.36,1.01] 
 Number of stillbirths  
     0 1,452 (98.2) 13,816 (98.2) 1.00 Not retained  1+ 26 (1.8) 247 (1.8) 1.00 [0.67,1.51] 
 Number of previous SGA infants 
     0† 1,207 (81.7) 12,810 (91.1) 1.00 1.00 
 1 215 (14.6) 1076 (7.7) 2.06 [1.75,2.42] 3.70 [3.02,  4.54] 9.81 [8.00,11.67]
2+ 56 (3.7) 177 (1.3) 3.26 [2.37,4.48] 7.56 [5.03,11.36] 3.11 [2.22,  4.13] 
Pre-existing/Gestational diabetes 114 (7.7) 1,487 (9.6) 0.71 [0.59,0.87] 0.60 [0.49, 0.74] 
 Pregnancy hypertension 597 (40.4) 2,150 (15.3) 3.73 [3.33,4.18] 4.46 [3.94, 5.05] 28.80 [25.97,31.64]
Chronic hypertension 64 (4.3) 376 (2.7) 1.66 [1.27,2.17] 3.12 [2.34, 4.16] 2.73 [1.80,    3.78] 
Placenta abruption 51 (3.5) 484 (3.4) 1.00 [0.74,1.34] Not retained 
 Placenta praevia 47 (3.2) 723 (5.1) 0.60 [0.44,0.82] Not retained 
 Urinary tract infection 30 (2.0) 314 (2.2) 0.91 [0.62,1.34] Not retained 
 Cardiac diseases 29 (2.0) 259 (1.8) 1.08 [0.73,1.59] Not retained 
 Chronic kidney disease 24 (1.6) 238 (1.7) 0.91 [0.60,1.39] Not retained 
 Asthma/Chronic obstructive pulmonary disease 38 (2.6) 379 (2.7) 0.95 [0.68,1.34] Not retained 
 Thyroid disorders 11 (0.7) 100 (0.7) 1.05 [0.56,1.97] Not retained 
 Autoimmune diseases 29 (2.0) 185 (1.3) 1.51 [1.02,2.24] Not retained 
 Alcohol use in pregnancy 6 (0.4) 30 (0.2) 1.92 [0.80,4.58] Not retained 
 Illicit drug dependency or abuse in pregnancy 57 (3.9) 247 (1.8) 2.21 [1.64,2.98] 1.82 [1.29,2.57] 1.45 [0.52,  2.43]
Smoking in pregnancy 380 (25.7) 2,271 (16.2) 1.79 [1.57,2.02] 2.23 [1.91,2.61] 12.41 [9.79.14.99] 
First antenatal care visit ≥14 weeks 1,141 (77.2) 11,129 (79.1) 1.11 [0.98,1.27] Not retained 
 Fetus with congenital anomaly 170 (11.5) 804 (5.7) 2.14 [1.80,2.55] 2.26 [1.86,2.74]  
SGA: small for gestational age, OR: odds ratio, CI: confidence interval, PAF: population attributable fraction, ARIA+:  
Accessibility/Remoteness Index of Australia 
     Estimated within-mother correlation: 0.057. 
† Reference category. For dichotomised variables, the reference category is absence of variable.  
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Table 2 – Crude and adjusted odds ratios and population attributable fractions for term SGA infants of diabetic mothers, New South 
Wales, 2007–2010 
Study variable Term infant, diabetic mother (≥37 weeks gestation) 
SGA  
(N = 1765) 
Non-SGA     
(N = 15,527) 
Crude OR 
 (95% CI) 
Adjusted OR 
 (95% CI) 
Model-based PAF 
 (95% CI) 
n (%) n (%) 
Country of birth and Aboriginality of the mother 
     Aboriginal Australian 35 (2.0) 344 (2.2) 1.35 [0.94,1.92] 1.08 [0.75,1.57] 
 Non-Aboriginal Australian† 628 (35.6) 8408 (54.2) 1.00 1.00 
 Non-Australian 1102 (62.4) 6775 (43.6) 2.17 [1.96,2.41] 1.92 [1.72,2.14] 
 ARIA+ remoteness 
     Major cities 1448 (82.0) 11,486 (74.0) 1.69 [1.46,1.94] 
Not retained  Inner regional† 240 (13.6) 3223 (20.8) 1.00  Outer regional 71 (4.0) 747 (4.8) 1.27 [0.96,1.68] 
 Remote 6 (0.3) 71 (0.4) 1.14 [0.49,2.66] 
 Maternal age 
     <20 years 23 (1.3) 186 (1.2) 0.96 [0.62,1.48] 
Not retained 
 20–24 years 131 (7.4) 1227 (7.9) 0.82 [0.67,1.00] 
 25–29 years† 485 (27.5) 3723 (24.0) 1.00 
 30–34 years 628 (35.6) 5503 (35.4) 0.87 [0.77,0.99] 
 35–39 years 399 (22.6) 3921 (25.3) 0.78 [0.68,0.89] 
 ≥40 years 99 (5.6) 967 (6.2) 0.78 [0.62,0.98] 
 Socio-economic group 
    
 
1st quintile (Most advantaged)† 301 (17.1) 3127 (20.1) 1.00 1.00 
2nd quintile 366 (20.7) 3194 (20.6) 1.19 [1.01,1.40] 1.15 [0.97,1.35] 
3rd quintile 278 (15.8) 3015 (19.4) 0.95 [0.80,1.13] 1.06 [0.89,1.26] 
4th quintile 252 (14.3) 2333 (15.0) 1.13 [0.94,1.35] 1.23 [1.02,1.47] 
5th quintile (Most disadvantaged) 568 (32.2) 3858 (24.9) 1.52 [1.31,1.77] 1.41 [1.21,1.64] 
 Inter-pregnancy interval 
     6–41 months, nulliparity† 1544 (87.5) 12,841 (82.7) 1.00 Not retained  <6 or ≥42 months 221 (12.5) 2686 (17.3) 1.29 [1.08,1.53] 
 Number of previous pregnancies 
     0 1189 (67.4) 7258 (46.7) 2.16 [1.92,2.42] 2.71 [2.38,3.09] 
 1† 399 (22.6) 5270 (33.9) 1.00 0.66 [0.53,0.83] 
 2 119 (6.7) 2063 (13.3) 0.77 [0.62,0.94] 0.56 [0.41,0.77] 
 3 52 (3.0) 660 (4.3) 1.03 [0.76,1.40] (0,2,3+ vs. 1)   4+ 6 (0.3) 276 (1.8) 0.28 [0.12,0.65] 
Number of previous births by caesarean  
     0† 1614 (91.4) 12,724 (82.0) 1.00 
Not retained  1 128 (7.3) 2182 (14.1) 0.47 [0.39,0.56] 
 2+ 23 (1.3) 621 (4.0) 0.29 [0.19,0.44] 
 Number of previous preterm births 
     0† 1704 (96.5) 14,827 (95.5) 1.00 Not retained  1+ 61 (3.5) 700 (4.5) 0.76 [0.58,0.99] 
 Number of stillbirths  
     0 1747 (99.0) 15,370 (99.0) 1.00 Not retained  1+ 18 (1.0) 157 (1.0) 1.02 [0.62,1.66] 
 Number of previous SGA infants 
     0† 1553 (88.0) 14,593 (94.0) 1.00 1.00 
 1 182 (10.3) 853 (5.5) 1.89 [1.58,2.25] 4.00 [3.28,  4.88] 7.27 [5.91,8.73]
2+ 30 (1.7) 78 (0.5) 3.40 [2.22,5.19] 8.93 [5.52,14.42] 1.44 [0.89,2.06] 
Pregnancy hypertension 206 (11.7) 1738 (11.2) 1.06 [0.91,1.23] Not retained 
 Chronic hypertension 35 (2.0) 408 (2.6) 0.75 [0.53,1.06] Not retained 
 Placenta abruption 6 (0.3) 37 (0.2) 1.44 [0.61,3.38] Not retained 
 Placenta praevia 17 (1.0) 208 (1.3) 0.73 [0.45,1.19] Not retained 
 Urinary tract infection 12 (0.7) 166 (1.1) 0.91 [0.62,1.34] Not retained 
 Cardiac diseases 11 (0.6) 226 (1.5) 0.64 [0.36,1.15] Not retained 
 Chronic kidney disease 15 (0.9) 112 (0.7) 0.42 [0.22,0.80] Not retained 
 Asthma/Chronic obstructive pulmonary disease 30 (1.7) 282 (1.8) 1.19 [0.70,2.05] Not retained 
 Thyroid disorders 16 (0.9) 137 (0.9) 0.93 [0.63,1.37] Not retained 
 Autoimmune diseases 11 (0.6) 119 (0.8) 1.01 [0.60,1.70] Not retained 
 Alcohol use in pregnancy 1 (0.1) 5 (0.0) 0.81 [0.44,1.49] Not retained 
 Illicit drug dependency or abuse in pregnancy 9 (0.5) 25 (0.2) 1.75 [1.48,6.80] 3.25 [1.46,7.22] 0.31 [0.04,0.64]
Smoking in pregnancy 162 (9.2) 1204 (7.8) 3.18 [1.48,6.80] 1.45 [1.21,1.75] 2.51 [1.14,3.92] 
First antenatal care visit ≥14 weeks 1389 (78.7) 12,355 (79.6) 1.20 [1.01,1.42] Not retained 
 Fetus with congenital anomaly 40 (2.3) 332 (2.1) 1.07 [0.77,1.48]         Not retained    
SGA: small for gestational age, OR: odds ratio, CI: confidence interval, PAF: population attributable fraction, ARIA+: 
Accessibility/Remoteness Index of Australia 
     Estimated within-mother correlation: 0.0004. 
† Reference category. For dichotomised variables, the reference category is absence of variable.  
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Table 3 – Crude and adjusted odds ratios and population attributable fractions for term SGA infants of non-diabetic mothers, New 
South Wales, 2007–2010 
Study variable  Term infant, non-diabetic mother (≥37 weeks gestation) 
SGA  
(N = 24,883) 
Non-SGA     
(N = 241,474) 
Crude OR 
 (95% CI) 
Adjusted OR 
 (95% CI) 
Model-based PAF 
 (95% CI) 
n (%) n (%) 
Country of birth and Aboriginality of the mother 
     Aboriginal Australian 1211 (4.9) 6617 (2.7) 2.09 [1.96,2.24] 1.29 [1.20,1.38] 
 Non-Aboriginal Australian† 14,883 (59.8) 169,582 (70.2) 1.00 1.00 
 Non-Australian 8789 (35.3) 65,275 (27.0) 1.54 [1.50,1.58] 1.54 [1.50,1.59] 
 ARIA+ remoteness 16,903 (67.9) 159,931 (66.2) 1.13 [1.09,1.17] 
  Major cities 
     Inner regional† 5636 (22.7) 60,177 (24.9) 1.00
Not retained 
 Outer regional 2076 (8.3) 19,322 (8.0) 1.14 [1.08,1.20] 
 Remote 199 (0.8) 1586 (0.7) 1.35 [1.15,1.57] 
 Very remote 69 (0.3) 458 (0.2) 1.59 [1.22,2.06] 
 Maternal age 1487 (6.0) 9343 (3.9) 1.42 [1.34,1.51] 
<20 years 
   
  
20–24 years 4577 (18.4) 35,742 (14.8) 1.15 [1.11,1.19]
Not retained 
 
25–29 years† 7590 (30.5) 68,353 (28.3) 1.00 
 30–34 years 7124 (28.6) 78,587 (32.5) 0.81 [0.79,0.84] 
35–39 years 3483 (14.0) 42,382 (17.6) 0.73 [0.70,0.77]  
≥40 years 622 (2.5) 7067 (2.9) 0.78 [0.71,0.85]  
Socio-economic group 
    
 
1st quintile (Most advantaged)† 4679 (18.8) 53,422 (22.1) 1.00 (1st–3rd quintiles 
vs. 4th, 5th quintile) 2
nd quintile 4917 (19.8) 51,171 (21.2) 1.10 [1.05,1.14] 
3rd quintile 4447 (17.9) 45,880 (19.0) 1.11 [1.06,1.16] 
4th quintile 4527 (18.2) 41,697 (17.3) 1.24 [1.19,1.29] 1.12 [1.08,1.16] 
5th quintile (Most disadvantaged) 6313 (25.4) 49,304 (20.4) 1.46 [1.40,1.52] 1.18 [1.15,1.22]  
Inter-pregnancy interval 22,050 (88.6) 210,389 (87.1) 1.00 1.00 
 6–41 months, nulliparity† 
     <6 or ≥42 months 2833 (11.4) 31,085 (12.9) 1.31 [1.25,1.37] 1.14 [1.08,1.19]
 Number of previous pregnancies 15,300 (61.5) 111,427 (46.1) 1.87 [1.81,1.92] 2.73 [2.62,2.84] 
 0 
     1† 6109 (24.6) 83,812 (34.7) 1.00 1.00
 2 2330 (9.4) 33,350 (13.8) 0.95 [0.90,0.99] 0.71 [0.67,0.74] 
 3 762 (3.1) 9429 (3.9) 1.08 [1.00,1.17] 0.55 [0.51,0.61] 
 4+ 382 (1.5) 3456 (1.4) 1.49 [1.33,1.66] 0.47 [0.41,0.55] 
Number of previous births by caesarean  
     0† 22,625 (90.9) 207,359 (85.9) 1.00 1.00 
 1 1847 (7.4) 27,258 (11.3) 0.62 [0.59,0.65] 0.92 [0.87,0.97] 
 2 337 (1.4) 5868 (2.4) 0.52 [0.47,0.58] (None vs. Any)  3+ 74 (0.3) 102 (0.4) 0.66 [0.52,0.83] 
 Number of previous preterm births 
     0† 23,960 (96.3) 234,357 (97.1) 1.00 1.00 
 1 852 (3.4) 6721 (2.8) 1.23 [1.14,1.32] 1.68 [1.55,1.82] 1.17 [0.95,  1.38]
2+ 71 (0.2) 396 (0.2) 1.73 [1.34,2.24] 2.00 [1.46,2.72] 0.11 [0.55,  0.17] 
Number of stillbirths  
     0 24,765 (99.5) 240,119 (99.4) 1.00 1.00 
 1+ 118 (0.5) 1355 (0.6) 0.84 [0.69,1.02] 1.40 [1.14,1.72] 0.12 [0.04,  0.20]
Number of previous SGA infants 
     0† 20,426 (82.1) 225,449 (93.4) 1.00 1.00 
 1 3666 (14.7) 14,624 (6.1) 2.41 [2.31,2.52] 4.90 [4.67,    5.14] 11.16 [10.73,11.62]
2 640 (2.6) 1198 (0.5) 5.42 [4.92,6.00] 12.27 [10.93,13.77] 2.24 [2.06,   2.43] 
3+ 151 (0.6) 203 (0.1) 7.70 [6.19,9.58] 16.89 [13.10,21.78] 0.54 [0.45,   0.65] 
Pregnancy hypertension 2422 (9.7) 20,690 (8.6) 1.16 [1.11,1.22] 1.17 [1.12,1.22] 1.22 [0.84,   1.89] 
Chronic hypertension 246 (1.0) 1913 (0.8) 1.24 [1.09,1.42] 1.31 [1.14,1.50] 0.20 [0.09,   0.32] 
Placenta abruption 102 (0.4) 552 (0.2) 1.78 [1.44,2.20] 1.54 [1.23,1.92]  
Placenta praevia 205 (0.8) 2176 (0.9) 0.92 [0.80,1.06] Not retained  
Urinary tract infection 281 (1.1) 2335 (1.0) 1.15 [1.02,1.31] Not retained  
Cardiac diseases 184 (0.7) 1676 (0.7) 1.07 [0.92,1.25] Not retained  
Chronic kidney disease 181 (0.7) 1588 (0.7) 1.08 [0.92,1.27] Not retained  
Asthma/Chronic obstructive pulmonary disease 483 (1.9) 4031 (1.7) 1.16 [1.05,1.28] Not retained  
Thyroid disorders 108 (0.4) 1093 (0.5) 0.96 [0.78,1.17] Not retained  
Autoimmune diseases 188 (0.8) 1860 (0.8) 0.97 [0.83,1.13] Not retained  
Alcohol use in pregnancy 44 (0.2) 135 (0.1) 2.96 [2.09,4.17] Not retained  
Illicit drug dependency or abuse in pregnancy 376 (1.5) 925 (0.4) 3.85 [3.40,4.35] 2.00 [1.74,2.29] 0.57 [0.44,  0.70] 
Smoking in pregnancy 5184 (20.8) 23,616 (9.8) 2.39 [2.31,2.47] 2.31 [2.22,2.40] 10.28 [9.77,10.83] 
First antenatal care visit ≥14 weeks 19,659 (79.0) 197,548 (81.8) 1.18 [1.14,1.22] 1.05 [1.01,1.08] 0.79 [0.20,  1.39] 
Fetus with congenital anomaly 730 (2.9) 4843 (2.0) 1.48 [1.37,1.60] 1.46 [1.35,1.59]   
SGA: small for gestational age, OR: odds ratio, CI: confidence interval, PAF: population attributable fraction, ARIA+:  
Accessibility/Remoteness Index of Australia 
     Estimated within-mother correlation: 0.022. 
† Reference category. For dichotomised variables, the reference category is absence of variable.  
 
